Table 3.

Correlation between nesfatin-1, vaspin levels, and maternal age, gravidity, body mass index (BMI), estimated fetal weight (EFW), gestational age and glucose levels in OGTT in patients with the GDM and control groups.

Variable	GDM				Control
	Nesfatin-1		Vaspin		Nesfatin-1		Vaspin
	R	p	R	p	R	p	R	p
Nesfatin-1			−0.471	p < 0.0001			−0.372	p < 0.001
Maternal age (years)	−0.261	NS	−0.230	p < 0.01	0.060	NS	−0.138	NS
Gravidity	−0.018	NS	−0.127	NS	0.138	NS	−0.022	NS
Pre-pregnancy BMI (kg/m2)	0.436	p < 0.0001	−0.713	p < 0.0001	0.403	p < 0.001	−0.613	p < 0.0001
BMI at sampling (kg/m2)	0.369	p < 0.001	−0.648	p < 0.0001	0.417	p < 0.001	−0.558	p < 0.001
Estimated fetal weight at sampling (g)	0.001	NS	−0.004	NS	0.201	NS	0.071	NS
Gestational age at sampling (weeks)	0.007	NS	−0.040	NS	0.274	p < 0.05	0.049	NS
Glucose
0′	0.382	p < 0.001	−0.371	p < 0.01	0.631	p < 0.0001	−0.514	p < 0.001
60′	0.514	p < 0.0001	−0.472	p < 0.001	0.565	p < 0.0001	−0.364	p < 0.01
120′	0.463	p < 0.0001	−0.575	p < 0.001	0.490	p < 0.0001	−0.348	p < 0.01

GDM: gestational diabetes mellitus; BMI: body mass index; R: Spearman correlation’s coefficient; p: statistical significance; NS: statistically not significant.